1. Introduction
===============

Microbiological transformations can be divided into two groups: xenobiotic biotransformations, in which the substrate is strange to the transforming organism, and biosynthetically-directed transformations, also known as "analogue biosynthesis", in which the substrate possesses a structure analogous to a natural biosynthetic intermediate found in the microorganism \[[@B1-molecules-17-01744],[@B2-molecules-17-01744]\]. We have carried out both types of biotransformations using the fungi *Mucor plumbeus* \[[@B3-molecules-17-01744]\] and *Gibberella fujikuroi* \[[@B4-molecules-17-01744]\] respectively. Now, in this work we have used another fungus, *Cephalosporium aphidicola*, which occupies the borderline between the xenobiotic and biosynthetically-directed biotransformations, because it achieves both \[[@B5-molecules-17-01744],[@B6-molecules-17-01744],[@B7-molecules-17-01744],[@B8-molecules-17-01744]\].

Diterpenes with a stemodane skeleton (*i.e*., **1**) have a structural similarity with aphidicolin (**2**), an antiviral substance and a inhibitor of DNA polymerase, which was isolated from *C. aphidicola* \[[@B9-molecules-17-01744]\], although the C/D ring junctions and the configuration at C-13 in stemodanes and aphidicolanes are different ([Scheme 1](#molecules-17-01744-f001){ref-type="fig"}). Thus, biotransformations of stemodane diterpenes, stemodin and stemodinone, with this fungus, have been carried out \[[@B10-molecules-17-01744],[@B11-molecules-17-01744]\]. Some of us had isolated 13α,17-dihydroxystemodane (**3**), and analogous compounds of this type, from *Stemonia chilensis*, a plant that grows in the littoral zone of central Chile \[[@B12-molecules-17-01744]\]. This compound had been incubated with *M. plumbeus* \[[@B13-molecules-17-01744]\], a fungus used in xenobiotic biotransformations.

![Stemodane (**1**) and aphidicolin (**2**).](molecules-17-01744-g001){#molecules-17-01744-f001}

2. Results and Discussion
=========================

The microbiological transformation of 13α,17-dihydroxystemodane (**3**) with the fungus *C. aphidicola* afforded 13α,17,18-trihydroxystemodane (**4**), 3β,13α,17-trihydroxystemodane (**5**), 13α,17-dihydroxystemodan-18-oic acid (**6**), 3β,11β,13α,17-tetrahydroxystemodane (**7**), 11β,13α,17,18-tetra-hydroxystemodane (**8**) and 3β,13α,17,18-tetrahydroxystemodane (**9**). Some of these metabolites were obtained as their acetates by acetylation of chromatographic fractions containing them.

The metabolite **4** showed in the HRMS spectrum the ion of higher mass at *m/z* 304.2407, formed from the molecular ion by loss of water, which indicated its molecular formula, C~20~H~34~O~3~. Thus, a new oxygen had been introduced in the molecule during the incubation. In the ^1^H-NMR spectrum the signal of a new AB system appears at δ 3.11 and 3.35 (1H each, d, *J =* 11 Hz). ^13^C-NMR spectrum showed a new signal at δ 72.6 (t). This last value is characteristic of an equatorial -CH~2~OH group at C-4 \[[@B14-molecules-17-01744],[@B15-molecules-17-01744]\], confirmed in the HMBC experiment with correlations of H-18 with C-3, and H-19 with C-3, C-5 and C-18. Therefore, the structure of this compound was determined as 13α,17,18-trihydroxystemodane (**4**).

Compound **6** was obtained as its diacetate **6a** by acetylation of the fractions containing it. The molecular formula of **6a** was determined as C~24~H~38~O~6~ considering HRMS data. Therefore, the substrate had gained two oxygens and lost two hydrogens during the fermentation. The two oxygens must form a part of an acid, because in the ^13^C-NMR spectrum a new signal was detected at δ 182.0, typical of this group, while the disappearance of a methyl signal was noted. The presence of this new group was confirmed because **6a** formed a methyl ester (compound **6am**) by treatment with diazomethane. We considered that the C-18 acid must be formed by oxidation of the corresponding alcohol in **4** ([Scheme 2](#molecules-17-01744-f002){ref-type="fig"}), and consequently assigned the structure of 13α,17-dihydroxystemodan-18-oic acid (**6**) to the original metabolite formed in the biotransformation.
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^13^C-NMR data of compounds **3**, **4**, **6a**, **6am**, **8a** and **9a** (CDCl~3~).

  Position   3      4          6a      6am     8a         9a
  ---------- ------ ---------- ------- ------- ---------- ------
  1          36.2   35.8       35.7    35.9    36.0 ^a^   33.5
  2          18.8   18.1       18.1    18.7    17.6       23.2
  3          41.8   35.2       36.8    36.8    36.3 ^b^   74.6
  4          33.2   37.6 ^a^   47.2    47.7    36.5       40.8
  5          47.2   40.4       41.6    41.9    41.1       39.5
  6          22.2   22.0       24.6    24.6    22.1       21.6
  7          36.6   36.2       36.7    36.7    34.6       36.1
  8          37.3   37.2       37.7    37.7    33.6       37.2
  9          50.7   50.8       50.6    50.6    55.0       50.9
  10         38.5   38.3 ^a^   37.9    38.0    39.1       38.1
  11         27.2   27.3       26.0    26.1    71.7       27.1
  12         28.1   28.2       27.0    27.1    36.6^b^    28.1
  13         74.3   74.2       84.4    84.5    74.0       74.6
  14         40.4   40.5       39.1    39.1    40.3       41.0
  15         37.4   37.4       35.2    35.2    35.5 ^a^   37.2
  16         29.7   29.8       29.8    29.9    28.4       29.4
  17         68.0   68.1       64.7    64.7    69.9       69.8
  18         34.5   72.6       182.0   179.6   73.3       65.9
  19         22.8   18.6       17.7    17.8    18.5       13.9
  20         18.8   19.6       19.0    19.0    20.6       19.4

^a,b^ These values can be interchanged

Compound **8** was obtained as its triacetate **8a**, the mass spectrum of which showed a peak at *m/z* 446.2687 formed from the molecular ion by loss of water. Thus, its molecular formula was determined as C~26~H~40~O~7~. Its NMR spectra showed two --CH~2~OAc groups, one corresponding to the acetylated C-17 alcohol of the substrate, and the other, formed by acetylation of an hydroxyl group introduced in the incubation, resonates at δ~H~ 3.61 and 3.98 (each 1H, d, *J =* 10.8 Hz) and at δ~C~ 73.3 (t). These signals are characteristic of an equatorial acetoxymethylene group at C-4 \[[@B14-molecules-17-01744],[@B15-molecules-17-01744]\]. Other signals observed in the spectra of **8a** were those of an oxymethine group at δ~H~ 5.36 (t, *J =* 7.6 Hz) and δ~C~ 71.7(d). These chemical shifts and couplings were analogous to those of an 11β-acetoxy derivative described in the biotransformation of the substrate **3** by *M. plumbeus* \[[@B13-molecules-17-01744]\]. The HMBC experiment of **8a** confirmed these assignments with the following crosspeaks: H-11 with C-8; H-18 with C-3, C-4 and C-5; H-19 with C-3, C-4, C-5 and C-18; H-20 with C-1, C-5, C-9 and C-10. Thus, the structure 11β,13α,17,18-tetrahydroxystemodane was assigned to the metabolite **8** ([Scheme 2](#molecules-17-01744-f002){ref-type="fig"}) obtained in this fermentation.

Acetylation and chromatography of the fractions containing **9** led to the triacetate **9a**, which is an isomer of **8a**. In addition to the signals of the 17-CH~2~OAc, in the ^1^H-NMR spectrum of the triacetate **8a** another acetoxymethylene group was detected at δ~H~ 3.67 and 3.88 (each 1H, d, *J =* 11.6 Hz) and δ~C~ 65.9(t), which was assigned to C-4 with an α-equatorial configuration. Thus, in the HMBC experiment the main observed correlations were: H-3 with C-1, C-2, C-4, C-18 and C-19; H-18 with C-3, C-5 and C-19; H-19 with C-3, C-4, C-5 and C-18. These crosspeaks also showed that another acetoxy group was located at C-3, with resonances of this oxymethine at δ~C~ 74.6 and δ~H~ 4.78 (dd, *J =* 11.7 and 4.1 Hz). The coupling constant of this geminal proton to this acetoxy group indicated a β-equatorial configuration for this oxygenated function. Consequently, the structure of the original alcohol formed in the feeding was determined as 3β,13α,17,18-tetrahydroxystemodane (**9**).

Compounds **4** and **6--9** are described here for the first time, whilst 3β,13α,17-trihydroxystemodane (**5**) and 3β,11β,13α,17-tetrahydroxystemodane (7) were already isolated from the biotransformation of **3** with *M. plumbeus*\[[@B13-molecules-17-01744]\].

![Biotransformation of **1** by *Cephalosporium aphidicola.*](molecules-17-01744-g002){#molecules-17-01744-f002}

3. Experimental
===============

3.1. General Procedures
-----------------------

^1^H- and ^13^C-NMR spectra were recorded at 500.13 and 125.03 MHz, respectively, in a Bruker AMX-500 spectrometer. Mass spectra were taken at 70 eV (probe) in a Micromass Autospec spectrometer. HPLC was performed using a Beckman System Gold 125P. Purification by HPLC was achieved using a silica gel column (Ultrasphere Si 5 μm, 10 × 250 mm). Dry column chromatography was carried out on silica gel Merck 0.040--0.063 mm.

3.2. Microorganism
------------------

The fungus strain *Cephalosporium aphidicola* IMI 68689 was a gift from Prof. J. R. Hanson, School of Chemistry, University of Sussex, UK.

3.3. Incubation of ***3***
--------------------------

*C. aphidicola* was grown in shake culture at 25 °C, in 20 conical flasks (250 mL), each containing 100 mL of a sterile medium comprising (per L) glucose (80 g), NH~4~NO~3~ (0.48 g), KH~2~PO~4~ (5 g), MgSO~4~ (1 g), and trace elements solution (2 mL). The trace elements solution contained (per 100 mL) Co(NO~3~)~2~ (0.01 g), CuSO~4~ (0.015 g), ZnSO~4~ (0.16 g), MnSO~4~ (0.01 g), (NH~4~)~6~Mo~7~O~24~ (0.01 g). 13α,17-Dihydroxystemodane (**3**, 230 mg) dissolved in EtOH (4.5 mL) was evenly distributed in 20 flasks after one day growth. After a further eight days, the fermentation was harvested. The mycelium was filtered and the culture filtrate was extracted with EtOAc. The extract was dried over Na~2~SO~4~ and the solvent evaporated to yield a residue (740 mg) that was chromatographed on a silica gel column in a petroleum ether-EtOAc gradient, to afford starting material **3** (30 mg), 13α,17,18-tri-hydroxystemodane (**4**, 4 mg), 3β,13α,17-trihydroxystemodane (**5**, 6 mg), 13α,17-dihydroxy-stemodane-18-oic acid (**6**) (1 mg), 3β,11β,13α,17-tetrahydroxystemodane (**7**, 2 mg), 11β, 13α,17,18-tetrahydroxystemodane (**8**, 1,5 mg) and 3β,13α,17,18-tetrahydroxystemodane (**9**, 3 mg).

*13α,17,18-Trihydroxystemodane* (**4**). ^1^H-NMR (CDCl~3~): δ 0.83 (3 H, s, H-19), 1.01 (3H, s, H-20), 1,60 (1H, dd, *J =* 11,4 and 2,4 Hz, H-5), 1.79 (2H, br s, H-16), 1.89 (1 H, ddt, *J =* 13.2, 7.4 and 3.1 Hz, H-7β), 2.15 (1H, br s, W~1/2~ = 16 Hz, H-14), 3.11 and 3.35 (each 1H, d, *J =* 11.0 Hz, H-18), 3.38 and 3.45 (each 1H, d, *J =* 10.9 Hz, H-17). EIMS *m/z* (rel. int.): 304 \[M−H~2~O\]^+^ (2), 291 (66), 286 (17), 273 (100), 255 (54), 230 (8), 215 (12), 206 (18), 203 (40), 173 (29), 159 (22). Found \[M−H~2~O\]^+^ at *m/z* 304.2407. C~20~H~32~O~2~ requires 304.2402.

*13α,17-Dihydroxystemodane-18-oic acid* (**6**). Obtained as its diacetate **5a** by acetylation and chromatography of the fractions containing it, ^1^H-NMR (CDCl~3~): δ 1.00 (3H, s, H-20), 1.25 (3H, s, H-19), 1.87 (2H, m, H-1 and H-16), 1.97 (1H, dd, *J =* 13.7 and 5.6 Hz, H-11), 2.05 and 2.06 (each 3H, s), 2.16 (1H, dd, *J =* 12.1 and 2.0 Hz, H-5), 2.80 (1 H, br t, *J =* 7.0 Hz, H-14), 4.36 and 4.51 (each 1H, d, *J =* 12.2 Hz, H-17). EIMS *m/z* (rel. int.): 360 \[M−C~2~H~4~O~2~\]^+^ (5), 318 (33), 305 (16), 300 (24), 285 (12), 277 (19), 255 (12), 239 (7), 220 (22), 204 (17), 184 (35), 159 (20). Found \[M-C~2~H~4~O~2~\]^+^ at *m/z* 360.2291. C~22~H~32~O~4~ requires 360.2301. *Acetate methyl ester* (**5am**). ^1^H-NMR (CDCl~3~): δ 1.00 (3H, s, H-20), 1.25 (3H, s, H-19), 2.04 and 2.06 (each 3H, s), 2.14 (1H, dd, *J =* 12.1 and 2.2 Hz, H-5), 2.81 (1 H, br t, *J =* 7.0 Hz, H-14), 3.65 (3H, s, -OMe), 4.35 and 4.51 (each 1H, d, *J =* 12.1 Hz, H-17). EIMS *m/z* (rel. int.): 374 \[M-C~2~H~4~O~2~\]^+^ (9), 332 (82), 314 (52), 299 (24), 277 (38), 255 (75), 239 (27), 234 (44), 220 (17), 199 (15), 185 (27). Found \[M−C~2~H~4~O~2~\]^+^ at *m/z* 374.2456. C~23~H~34~O~4~ requires 374.2457.

*11α,13α,17,18-Tetrahydroxystemodane* (**8**). Obtained as its triacetate **8a** from the fractions containing it, ^1^H-NMR (CDCl~3~): δ 0.89 (3H, s, H-19), 1.02 (3 H, s, H-20), 1.72 (2H, m, H-1 and H-15), 2.00, 2.06 and 2.08 (each 3H, s), 2.10 (1 H, m, H-14), 2.33 (1H, m, H-8) 3.61 and 3.98 (each 1H, d, *J =* 10.8 Hz, H-18), 3.96 and 3.99 (each 1 H, d, J 11.2 Hz, H-17), 5.36 (1H, t, *J =* 7.6 Hz, H-11). EIMS *m/z* (rel. int.): 446 \[M−H~2~O\]^+^ (1), 404 (2), 386 (33), 371 (6), 344 (23), 331 (21), 313 (10), 276 (14), 274 (13), 253 (17), 215 (76), 201 (14), 189 (47), 129 (100). Found \[M−H~2~O\]^+^ at *m/z* 446.2687. C~26~H~38~O~6~ requires 446.2668.

*3β,13α,17,18-Tetrahydroxystemodane* (**9**). Obtained as its triacetate **9a** from the fractions containing it, ^1^H-NMR (CDCl~3~): δ 0.90 (3 H, s, H-19), 1.03 (3H, s, H-20), 1.30 (2H, m, H-6), 1.74 (1H, m, H-8), 1.91 (2H, m, H-7 and H-16), 2.02, 2.07 and 2.09 (each 3H, s), 2.13 (1H, br t, *J =* 7.0 Hz, H-14), 3.67 and 3.88 (each 1H, d, J 11.6 Hz, H-18), 3.91 and 4.00 (each 1H, d, *J =* 11.3 Hz, H-17), 4.78 (1H, dd, J 11.7 and 4.1 Hz, H-3). EIMS *m/z* (rel. int.): 404 \[M−C~2~H~4~O~2~\]^+^ (6), 391 (24), 331 (9), 326 (29), 311 (14), 284 (16), 271 (14), 269 (12), 266 (49), 251 (39), 223 (17), 197 (14), 186 (100). Found \[M−C~2~H~4~O~2~\]^+^ at *m/z* 404.2544. C~23~H~35~O~5~ requires 404.2563.

4. Conclusions
==============

Several conclusions can be deduced from the microbiological transformation of 13α,17-dihydroxystemodane (**3**) with *C. aphidicola*:

1.  The hydroxylations produced in the substrate **3** by this fungus occurred at C-3(β), C-11(β) and C-18.

2.  The hydroxylation at C-18 points to a biosynthetically-directed transformation, since aphidicolin (2) is also hydroxylated at this carbon. This position was also functionalized in the biotransformation of stemodine and stemodinone with *C. aphidicola* \[[@B10-molecules-17-01744],[@B11-molecules-17-01744]\]. However, the C-3(β) and C-11(β) hydroxylations, also observed in the incubation of **3**, seem to indicate a xenobiotic biotransformation. These hydroxylations were also observed in the feeding of **3** with *M. plumbeus* \[[@B13-molecules-17-01744]\], a fungus used in the latter type.

3.  The oxidation of C-18 to acid level, as occurs in the formation of **6** from **4**, has now been observed for the first time in a biotransformation with *C. aphidicola*.

4.  It is probable that the formation of **9** only occurs from **4**, and not from **5**. Thus the hydroxylation of the C-18 methyl in **5** to form **9** could be inhibited by the presence of the equatorial β-hydroxyl group at C-3 ([Scheme 2](#molecules-17-01744-f002){ref-type="fig"}). In aphidicolin biosynthesis has been noted that an axial α-hydroxyl at C-3 blocks the hydroxylation of C-18 \[[@B8-molecules-17-01744]\], whilst in gibberellin biosynthesis has been observed that an equatorial 3α-OH inhibits hydroxylation of C-19 \[[@B16-molecules-17-01744]\].
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